<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31571717</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1998-3751</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>51</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2019</Year>
              <Season>Jul-Aug</Season>
            </PubDate>
          </JournalIssue>
          <Title>Indian journal of pharmacology</Title>
          <ISOAbbreviation>Indian J Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Quetiapine-induced leukocytoclastic vasculitis.</ArticleTitle>
        <Pagination>
          <StartPage>282</StartPage>
          <EndPage>283</EndPage>
          <MedlinePgn>282-283</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.4103/ijp.IJP_680_17</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ram</LastName>
            <ForeName>Dushad</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, JSS Medical College, JSS AHER, Mysuru, Karnataka, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mathur</LastName>
            <ForeName>Supriya</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Psychiatry, JSS Medical College, JSS AHER, Mysuru, Karnataka, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Indian J Pharmacol</MedlineTA>
        <NlmUniqueID>7902477</NlmUniqueID>
        <ISSNLinking>0253-7613</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>2S3PL1B6UJ</RegistryNumber>
          <NameOfSubstance UI="D000069348">Quetiapine Fumarate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C535509">Erythema elevatum diutinum</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069348" MajorTopicYN="N">Quetiapine Fumarate</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018366" MajorTopicYN="N">Vasculitis, Leukocytoclastic, Cutaneous</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>There are no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31571717</ArticleId>
        <ArticleId IdType="pmc">PMC6759529</ArticleId>
        <ArticleId IdType="doi">10.4103/ijp.IJP_680_17</ArticleId>
        <ArticleId IdType="pii">IJPharm-51-282</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Chew J, Cheong S, Tay L. Quetiapine-induced cutaneous vasculitis: Diagnostic challenges and therapeutic implications. J Am Geriatr Soc. 2016;64:1137–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27225367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loricera J, Calvo-Río V, Ortiz-Sanjuán F, González-López MA, Fernández-Llaca H, Rueda-Gotor J, et al.  The spectrum of paraneoplastic cutaneous vasculitis in a defined population: Incidence and clinical features. Medicine (Baltimore) 2013;92:331–43.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4553993</ArticleId>
            <ArticleId IdType="pubmed">24145696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vetlugina TP, Lobacheva OA, Semke AV, Nikitina VB, Bokhan NA. An effect of quetiapine on the immune system of patients with schizophrenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116:55–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27500878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mei F, Guo S, He Y, Wang L, Wang H, Niu J, et al.  Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation. PLoS One. 2012;7:e42746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3418290</ArticleId>
            <ArticleId IdType="pubmed">22912731</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
